Supplementary Table 1 from SOX4 Induces Epithelial–Mesenchymal Transition and Contributes to Breast Cancer Progression

Jianchao Zhang,Qian Liang,Yang Lei,Min Yao,Lili Li,Xiaoge Gao,Jingxin Feng,Yu Zhang,Hongwen Gao,Dong-Xu Liu,Jun Lu,Baiqu Huang

DOI: https://doi.org/10.1158/0008-5472.22393974

2023-01-01

Abstract:PDF file - 96K, New data of Oncomine analysis of SOX4 expression in human breast cancer tissues in comparison with normal breast tissues

What problem does this paper attempt to address?

Supplementary Table 2 from SOX4 Induces Epithelial–Mesenchymal Transition and Contributes to Breast Cancer Progression

Jianchao Zhang,Qian Liang,Yang Lei,Min Yao,Lili Li,Xiaoge Gao,Jingxin Feng,Yu Zhang,Hongwen Gao,Dong-Xu Liu,Jun Lu,Baiqu Huang

DOI: https://doi.org/10.1158/0008-5472.22393971.v1

2023-01-01

Abstract:PDF file - 157K, New data of Oncomine analysis of SOX4 expression in human breast cancer
Supplementary Figure 3 from SOX4 Induces Epithelial–Mesenchymal Transition and Contributes to Breast Cancer Progression

Jianchao Zhang,Qian Liang,Yang Lei,Min Yao,Lili Li,Xiaoge Gao,Jingxin Feng,Yu Zhang,Hongwen Gao,Dong-Xu Liu,Jun Lu,Baiqu Huang

DOI: https://doi.org/10.1158/0008-5472.22393995

2023-01-01

Abstract:<p>PDF file - 3.8MB, Overexpression of SOX4 induced EMT in MDCK cells</p>
Supplementary Figures 1-2 from SOX4 Induces Epithelial–Mesenchymal Transition and Contributes to Breast Cancer Progression

Jianchao Zhang,Qian Liang,Yang Lei,Min Yao,Lili Li,Xiaoge Gao,Jingxin Feng,Yu Zhang,Hongwen Gao,Dong-Xu Liu,Jun Lu,Baiqu Huang

DOI: https://doi.org/10.1158/0008-5472.22393983

2023-01-01

Abstract:PDF file - 1.5MB, Figure S1. The SOX4 mRNA level in MCF10A cells. Figure S2. Induction of SOX4 by other EMT-inducers
Supplementary Figure 4 from SOX4 Induces Epithelial–Mesenchymal Transition and Contributes to Breast Cancer Progression

Jianchao Zhang,Qian Liang,Yang Lei,Min Yao,Lili Li,Xiaoge Gao,Jingxin Feng,Yu Zhang,Hongwen Gao,Dong-Xu Liu,Jun Lu,Baiqu Huang

DOI: https://doi.org/10.1158/0008-5472.22393992.v1

2023-01-01

Abstract:PDF file - 1.8MB, SOX4 indirectly regulated E-cadherin transcription
Supplementary Figure 5 from SOX4 Induces Epithelial–Mesenchymal Transition and Contributes to Breast Cancer Progression

Jianchao Zhang,Qian Liang,Yang Lei,Min Yao,Lili Li,Xiaoge Gao,Jingxin Feng,Yu Zhang,Hongwen Gao,Dong-Xu Liu,Jun Lu,Baiqu Huang

DOI: https://doi.org/10.1158/0008-5472.22393986

2023-01-01

Abstract:PDF file - 3.6MB, Silencing of SOX4 in MDA-MB-231 and BT549 cells inhibited their invasive ability
Supplementary Figures 6-8 from SOX4 Induces Epithelial–Mesenchymal Transition and Contributes to Breast Cancer Progression

Jianchao Zhang,Qian Liang,Yang Lei,Min Yao,Lili Li,Xiaoge Gao,Jingxin Feng,Yu Zhang,Hongwen Gao,Dong-Xu Liu,Jun Lu,Baiqu Huang

DOI: https://doi.org/10.1158/0008-5472.22393980.v1

2023-01-01

Abstract:PDF file - 3.4MB, Figure S6. SOX4 alone was unable to induce tumor formation. Figure S7. Silencing of SOX4 reversed the EMTs in SOX4-expression MCF10A cells. Figure S8. Relative SOX4 mRNA expression levels in NMuMG cells treated with activated TGF-beta1 at indicated time and concentrations.
SOX4 Induces Epithelial–Mesenchymal Transition and Contributes to Breast Cancer Progression

Jianchao Zhang,Qian Liang,Yang Lei,Min Yao,Lili Li,Xiaoge Gao,Jingxin Feng,Yu Zhang,Hongwen Gao,Dong-Xu Liu,Jun Lu,Baiqu Huang

DOI: https://doi.org/10.1158/0008-5472.can-12-1045

IF: 11.2

2012-07-11

Cancer Research

Abstract:Epithelial-mesenchymal transition (EMT) is a developmental program, which is associated with breast cancer progression and metastasis. Here, we report that ectopic overexpression of SOX4 in immortalized human mammary epithelial cells is sufficient for acquisition of mesenchymal traits, enhanced cell migration, and invasion, along with epithelial stem cell properties defined by the presence of a CD44(high)/CD24(low) cell subpopulation. SOX4 positively regulated expression of known EMT inducers, also activating the TGF-β pathway to contribute to EMT. SOX4 itself was induced by TGF-β in mammary epithelial cells and was required for TGF-β-induced EMT. Murine xenograft experiments showed that SOX4 cooperated with oncogenic Ras to promote tumorigenesis in vivo. Finally, in clinical specimens of human breast cancer, we found that SOX4 was abnormally overexpressed and correlated with the triple-negative breast cancer subtype (ER(-)/PR(-)/HER2(-)). Our findings define an important function for SOX4 in the progression of breast cancer by orchestrating EMT, and they implicate this gene product as a marker of poor prognosis in this disease.

oncology
SOX4 promotes the growth and metastasis of breast cancer

The University of Texas MD Anderson Cancer Center,National Clinical Research Center of Cancer, Tianjin Medical University Cancer Institute and Hospital,The First Affiliated Hospital of Guangxi Medical University,Gong Yun,Sun Baohua,Li Zhongqi,Lu Yimin,Fei Xiaojie,Wu Weizhu,Sun Xiaoping,Teng Lisong

DOI: https://doi.org/10.1186/s12935-020-01568-2

IF: 6.429

2020-01-01

Cancer Cell International

Abstract:Increasing evidence has shown that the transcription factor SOX4 is closely associated with the development and progression of many malignant tumors. However, the effect of SOX4 on breast cancer is unclear. In this study, we purposed to investigate the role of SOX4 in the growth and metastasis in breast cancer and the underlying mechanism. Moreover, the effect of SOX4 on cancer cell resistance to chemotherapeutic agents was also evaluated in vitro and in vivo. We used lentivirus technique to ectopically express SOX4 in MDA-MB-231 and SUM149 cells or knockdown SOX4 in BT474 cells, and examined the effect of these changes on various cellular functions. MTT assay was used to determine the cell viability as well as resistance to chemotherapeutic agents. The regulation of SOX4 on epithelial-mesenchymal transition (EMT)-related genes was analyzed using qRT-PCR. The binding of SOX4 to the CXCR7 gene was demonstrated using chromatin immunoprecipitation assay and dual-luciferase reporter activity assay. The effect of SOX4/CXCR7 axis on metastasis was examined using Transwell migration and Matrigel invasion assays. The expression of SOX4/CXCR7 in primary tumors and metastatic foci in lymph nodes was assessed using immunohistochemistry. Cellular morphology was investigated under phase contrast microscope and transmission electron microscopy. Moreover, the effect of SOX4 on tumor growth, metastasis, and resistance to chemotherapy was also studied in vivo by using bioluminescent imaging. SOX4 increased breast cancer cell viability, migration, and invasion in vitro and enhanced tumor growth and metastasis in vivo. It regulated EMT-related genes and bound to CXCR7 promoter to upregulate CXCR7 transcription. Both SOX4 and CXCR7 were highly expressed in human primary tumors and metastatic foci in lymph nodes. Treatment of breast cancer cells with the CXCR7 inhibitor CCX771 reversed the SOX4 effect on cell migration and invasion. Ectopic expression of SOX4 increased the susceptibility of cells to paclitaxel. SOX4 plays an important role in the growth and metastasis of breast cancer. SOX4/CXCR7 may serve as potential therapeutic targets for the treatment. Paclitaxel may be a good therapeutic option if the expression level of SOX4 is high.
Table S2 from Epigenetic Regulation of CXCL12 Plays a Critical Role in Mediating Tumor Progression and the Immune Response in Osteosarcoma

Binghao Li,Zhan Wang,Hao Wu,Mingfeng Xue,Peng Lin,Shengdong Wang,Nong Lin,Xin Huang,Weibo Pan,Meng Liu,Xiaobo Yan,Hao Qu,Lingling Sun,Hengyuan Li,Yan Wu,Wangsiyuan Teng,Zenan Wang,Xingzhi Zhou,Huabiao Chen,Mark C. Poznansky,Zhaoming Ye

DOI: https://doi.org/10.1158/0008-5472.22419828

2023-01-01

Abstract:Supplementary Table S2. Patient characteristics
Table S1 from Epigenetic Regulation of CXCL12 Plays a Critical Role in Mediating Tumor Progression and the Immune Response in Osteosarcoma

Binghao Li,Zhan Wang,Hao Wu,Mingfeng Xue,Peng Lin,Shengdong Wang,Nong Lin,Xin Huang,Weibo Pan,Meng Liu,Xiaobo Yan,Hao Qu,Lingling Sun,Hengyuan Li,Yan Wu,Wangsiyuan Teng,Zenan Wang,Xingzhi Zhou,Huabiao Chen,Mark C. Poznansky,Zhaoming Ye

DOI: https://doi.org/10.1158/0008-5472.22419831

2023-01-01

Abstract:Supplementary Table S1. Primers for qRT-PCR and MSP
Table S3 from Epigenetic Regulation of CXCL12 Plays a Critical Role in Mediating Tumor Progression and the Immune Response in Osteosarcoma

Binghao Li,Zhan Wang,Hao Wu,Mingfeng Xue,Peng Lin,Shengdong Wang,Nong Lin,Xin Huang,Weibo Pan,Meng Liu,Xiaobo Yan,Hao Qu,Lingling Sun,Hengyuan Li,Yan Wu,Wangsiyuan Teng,Zenan Wang,Xingzhi Zhou,Huabiao Chen,Mark C. Poznansky,Zhaoming Ye

DOI: https://doi.org/10.1158/0008-5472.22419825.v1

2023-01-01

Abstract:Supplementary Table S3. Demographics of the included 332 osteosarcomas.
Silencing Sox2 Induced Mesenchymal-Epithelial Transition And Its Expression Predicts Liver And Lymph Node Metastasis Of Crc Patients

Xu Han,Xuefeng Fang,Xiaoyan Lou,Dasong Hua,Wenchao Ding,Gregory Foltz,Leroy Hood,Ying Yuan,Biaoyang Lin

DOI: https://doi.org/10.1371/journal.pone.0041335

IF: 3.7

2012-01-01

PLoS ONE

Abstract:SOX2 is an important stem cell marker and plays important roles in development and carcinogenesis. However, the role of SOX2 in Epithelial-Mesenchymal Transition has not been investigated. We demonstrated, for the first time, that SOX2 is involved in the Epithelial-Mesenchymal Transition (EMT) process as knock downof SOX2 in colorectal cancer (CRC) SW620 cells induced a Mesenchymal-Epithelial Transition (MET) process with recognized changes in the expression of key genes involved in the EMT process including E-cadherin and vimentin. In addition, we provided a link between SOX2 activity and the WNT pathway by showing that knock down of SOX2 reduced the WNT pathway activity in colorectal cancer (CRC) cells. We further demonstrated that SOX2 is involved in cell migration and invasion in vitro and in metastasis in vivo for CRC cells, and that the process might be mediated through the MMP2 activity. Finally, an IHC analysis of 44 cases of colorectal cancer patients suggested that SOX2 is a prognosis marker for metastasis of colorectal cancers.
Figure S4 from Epigenetic Regulation of CXCL12 Plays a Critical Role in Mediating Tumor Progression and the Immune Response in Osteosarcoma

Binghao Li,Zhan Wang,Hao Wu,Mingfeng Xue,Peng Lin,Shengdong Wang,Nong Lin,Xin Huang,Weibo Pan,Meng Liu,Xiaobo Yan,Hao Qu,Lingling Sun,Hengyuan Li,Yan Wu,Wangsiyuan Teng,Zenan Wang,Xingzhi Zhou,Huabiao Chen,Mark C. Poznansky,Zhaoming Ye

DOI: https://doi.org/10.1158/0008-5472.22419840

2023-01-01

Abstract:Supplementary figure S4. Immunofluorescence on intratumoral lymphocytes and qRT-PCR assays on TH1-type chemokine expression
Supplementary Data from SET Domain–Containing Protein 4 Epigenetically Controls Breast Cancer Stem Cell Quiescence

Sen Ye,Yan-Fu Ding,Wen-Huan Jia,Xiao-Li Liu,Jing-Yi Feng,Qian Zhu,Sun-Li Cai,Yao-Shun Yang,Qian-Yun Lu,Xue-Ting Huang,Jin-Shu Yang,Sheng-Nan Jia,Guo-Ping Ding,Yue-Hong Wang,Jiao-Jiao Zhou,Yi-Ding Chen,Wei-Jun Yang

DOI: https://doi.org/10.1158/0008-5472.22422729

2023-01-01

Abstract:Supplementary Table S1 and Supplementary Figure S1 to S11
Figure S3 from Epigenetic Regulation of CXCL12 Plays a Critical Role in Mediating Tumor Progression and the Immune Response in Osteosarcoma

Binghao Li,Zhan Wang,Hao Wu,Mingfeng Xue,Peng Lin,Shengdong Wang,Nong Lin,Xin Huang,Weibo Pan,Meng Liu,Xiaobo Yan,Hao Qu,Lingling Sun,Hengyuan Li,Yan Wu,Wangsiyuan Teng,Zenan Wang,Xingzhi Zhou,Huabiao Chen,Mark C. Poznansky,Zhaoming Ye

DOI: https://doi.org/10.1158/0008-5472.22419843.v1

2023-01-01

Abstract:Supplementary figure S3. Flow cytometry analyses of tumor draining lymph nodes.
SOX5 Predicts Poor Prognosis in Lung Adenocarcinoma and Promotes Tumor Metastasis Through Epithelial-Mesenchymal Transition

Xin Chen,Yufei Fu,Hongfei Xu,Peng Teng,Qiong Xie,Yiran Zhang,Caochong Yan,Yiqiao Xu,Chunqi Li,Jianying Zhou,Yiming Ni,Weidong Li

DOI: https://doi.org/10.18632/oncotarget.22443

2017-01-01

Oncotarget

Abstract:Lung cancer is the leading cause of cancer-related death worldwide. Epithelial-mesenchymal transition (EMT) promotes lung cancer progression and metastasis, especially in lung adenocarcinoma. Sex determining region Y-box protein 5 (SOX5) is known to stimulate the progression of various cancers. Here, we used immunohistochemical analysis to reveal that SOX5 levels were increased in 90 lung adenocarcinoma patients. The high SOX5 expression in lung adenocarcinoma and non-tumor counterparts correlated with the patients’ poor prognosis. Inhibiting SOX5 expression attenuated metastasis and progression in lung cancer cells, while over-expressing SOX5 accelerated lung adenocarcinoma progression and metastasis via EMT. An in vivo zebrafish xenograft cancer model also showed SOX5 knockdown was followed by reduced lung cancer cell proliferation and metastasis. Our results indicate SOX5 promotes lung adenocarcinoma tumorigenicity and can be a novel diagnosis and prognosis marker of the disease.
Supplementary Figure 5 from SOX9 is Essential for Triple-Negative Breast Cancer Cell Survival and Metastasis

Yu Ma,Jonathan Shepherd,Daqing Zhao,Lakshmi Reddy Bollu,William M. Tahaney,Jamal Hill,Yun Zhang,Abhijit Mazumdar,Powel H. Brown

DOI: https://doi.org/10.1158/1541-7786.22517661.v1

2023-01-01

Abstract:The association between SOX9 expression and overall survival or Metastasis-Free Survival in breast cancer patients
Supplementary Figure 11 from SOX9 is Essential for Triple-Negative Breast Cancer Cell Survival and Metastasis

Yu Ma,Jonathan Shepherd,Daqing Zhao,Lakshmi Reddy Bollu,William M. Tahaney,Jamal Hill,Yun Zhang,Abhijit Mazumdar,Powel H. Brown

DOI: https://doi.org/10.1158/1541-7786.22517688.v1

2023-01-01

Abstract:Mechanism of SOX9 regulating breast cancer survival
Supplementary Table S2 from Transcription Factor SOX18 Promotes Clear Cell Renal Cell Carcinoma Progression and Alleviates Cabozantinib-Mediated Inhibitory Effects

Han Yin,Chunxia Qin,Qiang Wang,Yun Du,Xuanming Ding,Tao Xu,Xiaowei Zhang,Qing Li,Shijun Liu

DOI: https://doi.org/10.1158/1535-7163.22509592

2023-01-01

Abstract:Information of antibodies used in the present study
Supplementary Data from SOX9 is Essential for Triple-Negative Breast Cancer Cell Survival and Metastasis

Yu Ma,Jonathan Shepherd,Daqing Zhao,Lakshmi Reddy Bollu,William M. Tahaney,Jamal Hill,Yun Zhang,Abhijit Mazumdar,Powel H. Brown

DOI: https://doi.org/10.1158/1541-7786.22517700.v1

2023-01-01

Abstract:Supplementary Figure Legends 1-16 and Supplementary Table Legends 1-4

Supplementary Table 1 from SOX4 Induces Epithelial–Mesenchymal Transition and Contributes to Breast Cancer Progression

Supplementary Table 2 from SOX4 Induces Epithelial–Mesenchymal Transition and Contributes to Breast Cancer Progression

Supplementary Figure 3 from SOX4 Induces Epithelial–Mesenchymal Transition and Contributes to Breast Cancer Progression

Supplementary Figures 1-2 from SOX4 Induces Epithelial–Mesenchymal Transition and Contributes to Breast Cancer Progression

Supplementary Figure 4 from SOX4 Induces Epithelial–Mesenchymal Transition and Contributes to Breast Cancer Progression

Supplementary Figure 5 from SOX4 Induces Epithelial–Mesenchymal Transition and Contributes to Breast Cancer Progression

Supplementary Figures 6-8 from SOX4 Induces Epithelial–Mesenchymal Transition and Contributes to Breast Cancer Progression

SOX4 Induces Epithelial–Mesenchymal Transition and Contributes to Breast Cancer Progression

SOX4 promotes the growth and metastasis of breast cancer

Table S2 from Epigenetic Regulation of CXCL12 Plays a Critical Role in Mediating Tumor Progression and the Immune Response in Osteosarcoma

Table S1 from Epigenetic Regulation of CXCL12 Plays a Critical Role in Mediating Tumor Progression and the Immune Response in Osteosarcoma

Table S3 from Epigenetic Regulation of CXCL12 Plays a Critical Role in Mediating Tumor Progression and the Immune Response in Osteosarcoma

Silencing Sox2 Induced Mesenchymal-Epithelial Transition And Its Expression Predicts Liver And Lymph Node Metastasis Of Crc Patients

Figure S4 from Epigenetic Regulation of CXCL12 Plays a Critical Role in Mediating Tumor Progression and the Immune Response in Osteosarcoma

Supplementary Data from SET Domain–Containing Protein 4 Epigenetically Controls Breast Cancer Stem Cell Quiescence

Figure S3 from Epigenetic Regulation of CXCL12 Plays a Critical Role in Mediating Tumor Progression and the Immune Response in Osteosarcoma

SOX5 Predicts Poor Prognosis in Lung Adenocarcinoma and Promotes Tumor Metastasis Through Epithelial-Mesenchymal Transition

Supplementary Figure 5 from SOX9 is Essential for Triple-Negative Breast Cancer Cell Survival and Metastasis

Supplementary Figure 11 from SOX9 is Essential for Triple-Negative Breast Cancer Cell Survival and Metastasis

Supplementary Table S2 from Transcription Factor SOX18 Promotes Clear Cell Renal Cell Carcinoma Progression and Alleviates Cabozantinib-Mediated Inhibitory Effects

Supplementary Data from SOX9 is Essential for Triple-Negative Breast Cancer Cell Survival and Metastasis